SCHEMBL13623264

SCHEMBL13623264

COc1ccc2cc(N3c4ccccc4Oc4cc(-c5ccc(-c6ccc7c(c6)Oc6ccccc6N7c6ccc7cc(OC)ccc7c6)c6ccccc56)ccc43)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.42
CYP11B2 P19099 4/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2B6 P20813 1/20 0.42
CYP2C19 P33261 1/20 0.42
GSTP1 P09211 1/20 0.38
CYP2A6 P11509 1/20 0.37
PTGS2 P35354 1/20 0.37
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
EDNRA P25101 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.34
P2RX4 Q99571 1/20 0.34
HSD17B1 P14061 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13623278 0.95 CYP1A2 (0.38) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL13623266 0.91 EDNRA (0.39) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL13623265 0.91 CYP11B2 (0.42) CYP11B1CYP11B2CYP1A2CYP3A4CYP2C9
SCHEMBL13623268 0.89 CYP11B1 (0.38) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL13623272 0.87 CYP2A6 (0.49) CYP11B1CYP11B2CYP1A2CYP2A6MEN1
SCHEMBL17206594 0.85 HSP90AA1 (0.35) CYP1A2CYP2C9CYP2C19GSTP1POLB
SCHEMBL14667911 0.83 CYP1A2 (0.41) CYP11B1CYP11B2CYP1A2CYP2A6MEN1
SCHEMBL13623271 0.82 CYP1A2 (0.40) CYP11B1CYP11B2CYP1A2CYP2A6MEN1
SCHEMBL13623249 0.81 HSP90AA1 (0.38) CYP1A2CYP2C9CYP2C19GSTP1POLB
SCHEMBL13030181 0.79 HSD17B1 (0.36) CYP11B1CYP11B2CYP1A2CYP2A6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same C1S, OR10J3, C1R CYP11B1 910/4885CYP11B2 1100/4885CYP1A2 180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.